Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells

EMBO J. 2010 Apr 21;29(8):1348-62. doi: 10.1038/emboj.2010.32. Epub 2010 Mar 11.

Abstract

Human immunodeficiency virus type 1 (HIV-1) transcription relies on its transactivating Tat protein. Although devoid of a signal sequence, Tat is released by infected cells and secreted Tat can affect uninfected cells, thereby contributing to HIV-1 pathogenesis. The mechanism and the efficiency of Tat export remained to be documented. Here, we show that, in HIV-1-infected primary CD4(+) T-cells that are the main targets of the virus, Tat accumulates at the plasma membrane because of its specific binding to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P(2)). This interaction is driven by a specific motif of the Tat basic domain that recognizes a single PI(4,5)P(2) molecule and is stabilized by membrane insertion of Tat tryptophan side chain. This original recognition mechanism enables binding to membrane-embedded PI(4,5)P(2) only, but with an unusually high affinity that allows Tat to perturb the PI(4,5)P(2)-mediated recruitment of cellular proteins. Tat-PI(4,5)P(2) interaction is strictly required for Tat secretion, a process that is very efficient, as approximately 2/3 of Tat are exported by HIV-1-infected cells during their lifespan. The function of extracellular Tat in HIV-1 infection might thus be more significant than earlier thought.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • CD4-Positive T-Lymphocytes / metabolism*
  • CD4-Positive T-Lymphocytes / virology*
  • Cell Membrane / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • HIV-1 / growth & development
  • HIV-1 / pathogenicity*
  • Humans
  • Jurkat Cells
  • Phosphatidylinositol 4,5-Diphosphate / metabolism*
  • Protein Binding
  • tat Gene Products, Human Immunodeficiency Virus / analysis
  • tat Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • Phosphatidylinositol 4,5-Diphosphate
  • tat Gene Products, Human Immunodeficiency Virus